Department of Clinical Sciences, Lund University, Malmö, Sweden.
J Intern Med. 2014 Aug;276(2):174-83. doi: 10.1111/joim.12188. Epub 2014 Jan 28.
Hyperglycaemia has multiple effects on the red blood cell (RBC), including glycation of haemoglobin, reduced deformability and reduced lifespan. Red cell distribution width (RDW) is a measure of the heterogeneity of erythrocyte volumes. The aim of this study was to explore the relationships between RDW and glucose, haemoglobin A1c (HbA1c) and incidence of diabetes mellitus (DM).
DESIGN, SETTING AND SUBJECTS: RDW and mean corpuscular volume were measured in 26 709 non-diabetic participants (aged 45-73 years) from the population-based Malmö Diet and Cancer cohort. HbA1c and fasting venous blood glucose levels were measured in 4845 subjects.
Incidence of DM (n = 2944) over 14 years of follow-up was studied by linkage with national and local DM registers.
Individuals with low RDW had significantly higher risk of developing DM [adjusted hazard ratio (HR) 1.48, 95% confidence interval (CI) 1.29-1.70, for 1st vs. 4th quartile], especially in subjects with impaired fasting glucose (n = 416) (HR 2.15, 95% CI 1.12-4.14). Low RDW was also associated with significantly higher waist circumference and glucose, insulin and triglyceride concentrations. By contrast, RDW was significantly and positively associated with HbA1c, corresponding an increase in HbA1c of 0.10% per 1 SD increase in RDW.
Low RDW is associated with increased incidence of DM independently of other risk factors. We propose that low RDW could be a surrogate marker of reduced RBC survival, with lower HbA1c due to shorter duration of glucose exposure. RDW is a biomarker that could improve risk assessment for individuals at risk of developing DM.
高血糖对红细胞(RBC)有多种影响,包括血红蛋白糖化、变形能力降低和寿命缩短。红细胞分布宽度(RDW)是红细胞体积异质性的一种衡量指标。本研究旨在探讨 RDW 与血糖、糖化血红蛋白(HbA1c)和糖尿病(DM)发病率之间的关系。
设计、地点和对象:在来自人群基础的马尔默饮食与癌症队列的 26709 例非糖尿病参与者(年龄 45-73 岁)中测量了 RDW 和平均红细胞体积。在 4845 例患者中测量了 HbA1c 和空腹静脉血糖水平。
通过与国家和地方 DM 登记处的关联,研究了 14 年随访期间 DM(n=2944)的发病率。
低 RDW 个体发生 DM 的风险显著升高[校正后的危险比(HR)1.48,95%置信区间(CI)1.29-1.70,第 1 四分位数比第 4 四分位数],尤其是在空腹血糖受损(n=416)的患者中(HR 2.15,95%CI 1.12-4.14)。低 RDW 还与腰围和血糖、胰岛素和甘油三酯浓度显著升高相关。相反,RDW 与 HbA1c 显著正相关,RDW 每增加 1 SD,HbA1c 相应增加 0.10%。
低 RDW 与其他危险因素独立相关,与 DM 发病率增加相关。我们提出,低 RDW 可能是红细胞寿命降低的替代标志物,由于葡萄糖暴露时间较短,HbA1c 降低。RDW 是一种可以改善发生 DM 风险个体风险评估的生物标志物。